BackClover Health Investments Overview
Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Price to Sales

Latest P/S ratio for Clover Health Investments: 1.08 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Price to Sales

1.07

Price to Sales

1.07

Price-to-Sales ratio compares a company's stock price to its revenue per share. A lower P/S ratio may indicate that the stock is undervalued relative to its sales.

Price to Sales (Comparison Companies)

Loading

Price to Sales History

Loading

Price to Sales Comparison

Loading

Clover Health Investments (CLOV) FAQ

As of the most recent data, CLOV shows a P/S ratio of 1.08. That is below the Finance sector average of 3.36. Scroll down for historical charts and peer comparison views.

The Finance sector average P/S ratio is about 3.36. Clover Health Investments is at 1.08, which is lower that average. That is roughly 68.0% below the sector mean. Use the comparison chart on this page to see how CLOV stacks up against individual peers as well.

Investors watch CLOV's P/S ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Clover Health Investments's latest reading is 1.08. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this price-to-sales ratio page, Stockcircle has Clover Health Investments's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/S ratio (currently 1.08) with ownership activity and broader fundamentals.

The Finance average P/S ratio is about 3.36, while CLOV is at 1.08. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.